Lilly's OVERCOME Study Reveals Less than 30 Percent of People Living with Migraine Take Recommended Prescription Medications
"For millions of people living with migraine, the journey to an appropriate treatment program is fraught with gaps," said
Using data from OVERCOME, the authors assessed the proportion of people living with migraine and migraine-related disability - as measured by the Migraine Disability Assessment Scale (MIDAS) - who completed three critical steps in migraine management: 1) actively sought care with a healthcare professional, 2) received a migraine diagnosis, and 3) took a recommended prescription medication1. The objectives were to assess how many respondents completed each step and to understand migraine-related characteristics such as migraine pain severity and related disability, sociodemographic features and where respondents sought care for their migraine.
Among OVERCOME respondents with migraine who may benefit from acute prescription medication and experienced at least mild migraine-related disability (MIDAS>6) (n=12,212), 63 percent sought care (n=7,695) and of those, 75 percent were diagnosed with migraine (n=5,802). Within the diagnosed population, only 59 percent took a recommended acute prescription medication (n=3,401). Overall, only 28 percent of the population completed all three steps to appropriate care.
Among OVERCOME respondents who were candidates for a preventive medication (n=5,873), which includes people who experienced four or more migraine headache days per month and moderate or severe migraine-related disability (MIDAS >11), 69 percent sought care (n=4,053) and of those, 79 percent received a migraine diagnosis (n=3,218). Of those who sought care and received a diagnosis, only 28 percent took a preventive medication for migraine (n=902). Overall, only 15 percent of this population completed all three steps to appropriate care.
"Even in light of recent new treatment options in the field of migraine, we still face an uphill battle as too many continue to be underserved," said
For both populations, possessing health insurance and higher levels of migraine-related disability increased the likelihood that respondents would complete all three steps. Another common theme across both populations was approximately 10 percent of respondents sought care in an emergency room, urgent care or retail clinic setting only and as a result, were unlikely to receive an accurate diagnosis or take a recommended medication.
"The OVERCOME study provides a snapshot into the current state of migraine in America, while reminding us there is much work to be done," said
About the OVERCOME Study
The Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) study aims to further understand the burden of migraine and stigma experienced by people living with the disease, identify barriers to the appropriate treatment of migraine and assess how the introduction of novel treatment options may influence delivery of migraine care and outcomes.
The OVERCOME study is a prospective, web-based patient survey designed to follow
The OVERCOME study is being conducted by Kantar on behalf of
Richard B. Lipton(Study Chair), M.D., Department of Neurology, Albert Einstein College of Medicineand Director, Montefiore Headache Center, Montefiore Health System Sait Ashina, M.D., Department of Neurologyand Department of Anesthesia, Critical Care and Pain Medicine, and Harvard Medical School, Beth Israel Deaconess Medical Center Dawn C. Buse, Ph.D., Department of Neurology, Albert Einstein College of Medicine, Clinical Health Psychology Doctoral Program of the Ferkauf Graduate School of Psychology, Yeshiva University Susan Hutchinson, M.D., Orange County Migraine and Headache Center Michael L. Reed, Ph.D., President, Vedanta Research Robert E. Shapiro, M.D., Department of Neurological Sciences, Larner College of Medicine, University of Vermont
1 Recommended medications refer to those with established/probable efficacy as identified by the
Kevin Hern; email@example.com; 317-277-1838 (Investor Relations)
View original content to download multimedia:http://www.prnewswire.com/news-releases/lillys-overcome-study-reveals-less-than-30-percent-of-people-living-with-migraine-take-recommended-prescription-medications-301077182.html